244 related articles for article (PubMed ID: 6166244)
1. Comparison of the effects of arabinosyladenine, arabinosylhypoxanthine, and arabinosyladenine 5'-monophosphate against herpes simplex virus, varicella-zoster virus, and cytomegalovirus with their effects on cellular deoxyribonucleic acid synthesis.
Gephart JF; Lerner AM
Antimicrob Agents Chemother; 1981 Jan; 19(1):170-8. PubMed ID: 6166244
[TBL] [Abstract][Full Text] [Related]
2. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination.
Champney KJ; Lauter CB; Bailey EJ; Lerner AM
J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in the presence of an adenosine deaminase inhibitor.
Schwartz PM; Shipman C; Drach JC
Antimicrob Agents Chemother; 1976 Jul; 10(1):64-74. PubMed ID: 185947
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in synchronized suspension cultures.
Shipman C; Smith SH; Carlson RH; Drach JC
Antimicrob Agents Chemother; 1976 Jan; 9(1):120-7. PubMed ID: 176927
[TBL] [Abstract][Full Text] [Related]
5. Effect of ara-T on the replication of herpes simplex virus, varicella-zoster virus and cytomegalovirus.
Miller RL; Iltis JP; Rapp F
IARC Sci Publ (1971); 1978; (24 Pt 2):991-7. PubMed ID: 221418
[TBL] [Abstract][Full Text] [Related]
6. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of phosphonoformic acid-resistant herpes simplex virus variants to arabinosylnucleosides and aphidicolin.
Bastow KF; Derse DD; Cheng YC
Antimicrob Agents Chemother; 1983 Jun; 23(6):914-7. PubMed ID: 6311091
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the antiviral effects of 5-methoxymethyldeoxyuridine-5'-monophosphate with adenine arabinoside-5'-monophosphate.
Ayisi NK; Meldrum JB; Stuart AL; Gupta VS
Antiviral Res; 1983 Sep; 3(3):161-74. PubMed ID: 6197027
[TBL] [Abstract][Full Text] [Related]
9. Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice.
Schinazi RF; Peters J; Williams CC; Chance D; Nahmias AJ
Antimicrob Agents Chemother; 1982 Sep; 22(3):499-507. PubMed ID: 6182836
[TBL] [Abstract][Full Text] [Related]
10. Comparison of susceptibilities of varicella-zoster virus and herpes simplex viruses to nucleoside analogs.
Machida H
Antimicrob Agents Chemother; 1986 Mar; 29(3):524-6. PubMed ID: 3013088
[TBL] [Abstract][Full Text] [Related]
11. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir.
Standring-Cox R; Bacon TH; Howard BA
J Virol Methods; 1996 Jan; 56(1):3-11. PubMed ID: 8690764
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico.
Conde-Glez C; Lazcano-Ponce E; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E
Vaccine; 2013 Oct; 31(44):5067-74. PubMed ID: 24021305
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
Suzuki M; Okuda T; Shiraki K
Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
[TBL] [Abstract][Full Text] [Related]
14. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus.
Earnshaw DL; Bacon TH; Darlison SJ; Edmonds K; Perkins RM; Vere Hodge RA
Antimicrob Agents Chemother; 1992 Dec; 36(12):2747-57. PubMed ID: 1336346
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of DNA synthesis in varicella-zoster virus-infected cells by BV-araU.
Machida H; Watanabe Y
Microbiol Immunol; 1991; 35(2):139-45. PubMed ID: 1653394
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiviral activity of 6-chloropurine arabinoside and its 2'-deoxy-2'-fluoro derivative.
Maruyama T; Sato Y; Oto Y; Takahashi Y; Snoeck R; Andrei G; Witvrouw M; De Clercq E
Chem Pharm Bull (Tokyo); 1996 Dec; 44(12):2331-4. PubMed ID: 8996865
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.
Coen DM; Fleming HE; Leslie LK; Retondo MJ
J Virol; 1985 Feb; 53(2):477-88. PubMed ID: 2982032
[TBL] [Abstract][Full Text] [Related]
18. Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs.
Marcelletti JF
Antiviral Res; 2002 Nov; 56(2):153-66. PubMed ID: 12367721
[TBL] [Abstract][Full Text] [Related]
19. Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents.
Thomsen DR; Oien NL; Hopkins TA; Knechtel ML; Brideau RJ; Wathen MW; Homa FL
J Virol; 2003 Feb; 77(3):1868-76. PubMed ID: 12525621
[TBL] [Abstract][Full Text] [Related]
20. The antiviral spectrum of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
De Clercq E
J Antimicrob Chemother; 1984 Aug; 14 Suppl A():85-95. PubMed ID: 6092320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
